Nuveen Asset Management’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-205,187
| Closed | -$35.3M | – | 3367 |
|
2021
Q3 | $35.3M | Sell |
205,187
-65,199
| -24% | -$11.2M | 0.01% | 883 |
|
2021
Q2 | $33.9M | Sell |
270,386
-1,795
| -0.7% | -$225K | 0.01% | 984 |
|
2021
Q1 | $36.9M | Sell |
272,181
-8,162
| -3% | -$1.11M | 0.01% | 899 |
|
2020
Q4 | $35.9M | Buy |
280,343
+76,766
| +38% | +$9.82M | 0.01% | 883 |
|
2020
Q3 | $22.9M | Buy |
203,577
+54,518
| +37% | +$6.13M | 0.01% | 978 |
|
2020
Q2 | $14.2M | Sell |
149,059
-230,040
| -61% | -$21.9M | 0.01% | 1256 |
|
2020
Q1 | $34.1M | Buy |
379,099
+186,736
| +97% | +$16.8M | 0.02% | 634 |
|
2019
Q4 | $10.2M | Sell |
192,363
-546
| -0.3% | -$28.9K | ﹤0.01% | 1581 |
|
2019
Q3 | $7.62M | Sell |
192,909
-1,423
| -0.7% | -$56.2K | ﹤0.01% | 1730 |
|
2019
Q2 | $7.98M | Buy |
+194,332
| New | +$7.98M | ﹤0.01% | 1743 |
|